Regulation of DREAM Expression by Group I mGluR |
Lee, Jin-U
(Department of Pharmacology, Yonsei University College of Medicine)
Kim, In-Sook (Division of Metabolic Disease, Department of Biomedical Science, National Institutes of Health) Oh, So-Ra (Department of Pharmacology, Yonsei University College of Medicine) Ko, Suk-Jin (Department of Pharmacology, Yonsei University College of Medicine) Lim, Mi-Kyung (Department of Pharmacology, Yonsei University College of Medicine) Kim, Dong-Goo (Department of Pharmacology, Yonsei University College of Medicine) Kim, Chul-Hoon (Department of Pharmacology, Yonsei University College of Medicine) |
1 | Buxbaum JD. A role for calsenilin and related proteins in multiple aspects of neuronal function. Biochem Biophys Res Commun. 2004;322:1140-1144. DOI ScienceOn |
2 | Cheng HY, Pitcher GM, Laviolette SR, Whishaw IQ, Tong KI, Kockeritz LK, Wada T, Joza NA, Crackower M, Goncalves J, Sarosi I, Woodgett JR, Oliveira-dos-Santos AJ, Ikura M, van der Kooy D, Salter MW, Penninger JM. DREAM is a critical transcriptional repressor for pain modulation. Cell. 2002;108:31-43. DOI ScienceOn |
3 | Buxbaum JD, Choi EK, Luo Y, Lilliehook C, Crowley AC, Merriam DE, Wasco W. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat Med. 1998;4:1177-1181. DOI ScienceOn |
4 | An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KI, Strassle BW, Trimmer JS, Rhodes KJ. Modulation of A-type potassium channels by a family of calcium sensors. Nature. 2000;403:553-556. DOI ScienceOn |
5 | Carrion AM, Link WA, Ledo F, Mellstrom B, Naranjo JR. DREAM is a -regulated transcriptional repressor. Nature.1999;398:80-84. DOI ScienceOn |
6 | Jo DG, Lee JY, Hong YM, Song S, Mook-Jung I, Koh JY, Jung YK. Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer's disease and cultured neurons after amyloid-beta exposure. J Neurochem. 2004;88:604-611. DOI ScienceOn |
7 | Hu HJ, Alter BJ, Carrasquillo Y, Qiu CS, Gereau RW 4th. Metabotropic glutamate receptor 5 modulates nociceptive plasticity via extracellular signal-regulated kinase-Kv4.2 signaling in spinal cord dorsal horn neurons. J Neurosci. 2007;27:13181-13191. DOI ScienceOn |
8 | Sevostianova N, Danysz W. Analgesic effects of mGlu1 and mGlu5 receptor antagonists in the rat formalin test. Neuropharmacology. 2006;51:623-630. DOI ScienceOn |
9 | Kolber BJ, Montana MC, Carrasquillo Y, Xu J, Heinemann SF, Muglia LJ, Gereau RW 4th. Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior. J Neurosci. 2010;30:8203-8213. DOI ScienceOn |
10 | Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, Flor PJ, Vranesic I, Lingenhoehl K, Johnson EC, Varney M, Urban L, Kuhn R. Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology. 2001;40:1-9. DOI |
11 | McGarrigle D, Huang XY. GPCRs signaling directly through Src-family kinases. Sci STKE. 2007;2007:pe35. |
12 | Burgoyne RD. Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci. 2007; 8:182-193. DOI |
13 | Sun Y, McGarrigle D, Huang XY. When a G protein-coupled receptor does not couple to a G protein. Mol Biosyst. 2007;3:849-854. DOI ScienceOn |
14 | Costigan M, Woolf CJ. No DREAM, No pain. Closing the spinal gate. Cell. 2002;108:297-300. DOI ScienceOn |
15 | Osawa M, Dace A, Tong KI, Valiveti A, Ikura M, Ames JB. and differentially regulate DNA binding and dimerization of DREAM. J Biol Chem. 2005;280:18008-18014. DOI |
16 | Francesconi A, Duvoisin RM. Role of the second and third intracellular loops of metabotropic glutamate receptors in mediating dual signal transduction activation. J Biol Chem. 1998;273:5615-5624. DOI |
17 | Lee JH, Lee J, Choi KY, Hepp R, Lee JY, Lim MK, Chatani-Hinze M, Roche PA, Kim DG, Ahn YS, Kim CH, Roche KW. Calmodulin dynamically regulates the trafficking of the metabotropic glutamate receptor mGluR5. Proc Natl Acad Sci USA. 2008;105:12575-12580. DOI ScienceOn |
18 | Zaidi NF, Thomson EE, Choi EK, Buxbaum JD, Wasco W. Intracellular calcium modulates the nuclear translocation of calsenilin. J Neurochem. 2004;89:593-601. DOI ScienceOn |
19 | Woo HN, Chang JW, Choi YH, Gwon AR, Jung YK, Jo DG. Characterization of subcellular localization and modulation of calsenilin/DREAM/KChIP3. Neuroreport. 2008;19:1193-1197. DOI ScienceOn |
20 | Niswender CM, Conn PJ. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol. 2010;50:295-322. DOI ScienceOn |
21 | Ribeiro FM, Paquet M, Cregan SP, Ferguson SS. Group I metabotropic glutamate receptor signalling and its implication in neurological disease. CNS Neurol Disord Drug Targets. 2010;9:574-595. DOI ScienceOn |
22 | Dolen G, Carpenter RL, Ocain TD, Bear MF. Mechanism-based approaches to treating fragile X. Pharmacol Ther. 2010;127:78-93. DOI ScienceOn |
23 | Cho CH, Shin HK. Spinal metabotropic glutamate receptors (mGluRs) are involved in the melittin-induced nociception in rats. Korean J Physiol Pharmacol. 2008;12:237-243. DOI |
24 | Krystal JH, Mathew SJ, D'Souza DC, Garakani A, Gunduz-Bruce H, Charney DS. Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs. 2010;24:669-693. DOI ScienceOn |
25 | Brackmann M, Zhao C, Kuhl D, Manahan-Vaughan D, Braunewell KH. MGluRs regulate the expression of neuronal calcium sensor proteins NCS-1 and VILIP-1 and the immediate early gene arg3.1/arc in the hippocampus in vivo. Biochem Biophys Res Commun. 2004;322:1073-1079. DOI ScienceOn |